Literature DB >> 8723556

Granulocyte-colony stimulating factor produced by pancreatic carcinoma.

T Uematsu1, K Tsuchie, K Ukai, E Kimoto, T Funakawa, R Mizuno.   

Abstract

CONCLUSION: A rare case of granulocyte-colony stimulating factor (G-CSF) produced by carcinoma of the pancreas has been reported.
BACKGROUND: This is the first case showing high G-CSF concentration in the aspirated tumor fluid (mucin) at its early stage without leukocytosis.
METHODS: The tumor, detected incidentally in a 64-yr-old male, was removed by a distal pancreatectomy. The mass was 7.0 x 6.5 x 4.5 cm, and was histologically diagnosed as cystadenocarcinoma with prominent sarcomatous transformation. It was classified as anaplastic carcinoma.
RESULTS: After 4 wk of resection, progressive leukocytosis was observed. Seven weeks after the operations, the peripheral leukocyte count increased to 126,000/mL. After 8 wk of resection, the patient died of recurrence. The serum G-CSF concentration was elevated after recurrence. The preserved mucin contained in the cystic components of the resected specimen had a G-CSF concentration higher than 2400 pg/mL. G-CSF is a known cytokine and an etiologic agent in paraneoplastic syndromes. An early diagnosis can, therefore, be made prior to the manifestation of clinical symptoms by the evaluation of the aspirated tumor fluid. This can lead to the prevention of the paraneoplastic syndrome with inhibitory cytokines in future.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8723556     DOI: 10.1007/BF02805227

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  15 in total

1.  Unusual leukocyte responses in primary carcinoma of the lung.

Authors:  R J FAHEY
Journal:  Cancer       Date:  1951-09       Impact factor: 6.860

2.  Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay.

Authors:  K Watari; S Asano; N Shirafuji; H Kodo; K Ozawa; F Takaku; S Kamachi
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

3.  [Colony stimulating factor producing carcinoma of the pancreas--a case report].

Authors:  S Ohwada; Y Miyamoto; T Fujii; T Kuribara; O Teshigawara; T Oyama; H Ishii; T Joshita; M Izuo
Journal:  Gan No Rinsho       Date:  1989-03

4.  Quantitative enzyme immunoassay for human granulocyte colony stimulating factor (G-CSF).

Authors:  H Motojima; T Kobayashi; M Shimane; S Kamachi; M Fukushima
Journal:  J Immunol Methods       Date:  1989-03-31       Impact factor: 2.303

5.  The growth of mouse bone marrow cells in vitro.

Authors:  T R Bradley; D Metcalf
Journal:  Aust J Exp Biol Med Sci       Date:  1966-06

6.  Establishment of specific monoclonal antibodies against recombinant human granulocyte colony-stimulating factor (hG-CSF) and their application for immunoperoxidase staining of paraffin-embedded sections.

Authors:  K Shimamura; J Fujimoto; J Hata; A Akatsuka; Y Ueyama; T Watanabe; N Tamaoki
Journal:  J Histochem Cytochem       Date:  1990-02       Impact factor: 2.479

7.  Purification of a colony-stimulating factor from cultured pancreatic carcinoma cells.

Authors:  M Wu; J K Cini; A A Yunis
Journal:  J Biol Chem       Date:  1979-07-25       Impact factor: 5.157

8.  Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines.

Authors:  M P Colombo; C Maccalli; S Mattei; C Melani; M Radrizzani; G Parmiani
Journal:  Melanoma Res       Date:  1992-09       Impact factor: 3.599

Review 9.  The nature and action of granulocyte-macrophage colony stimulating factors.

Authors:  A W Burgess; D Metcalf
Journal:  Blood       Date:  1980-12       Impact factor: 22.113

Review 10.  The cytokine network.

Authors:  F R Balkwill; F Burke
Journal:  Immunol Today       Date:  1989-09
View more
  7 in total

Review 1.  Much More than Trousseau Syndrome. The Broad Spectrum of the Pancreatic Paraneoplastic Syndromes.

Authors:  Attila Zalatnai; Eszter Perjési; Eszter Galambos
Journal:  Pathol Oncol Res       Date:  2017-02-03       Impact factor: 3.201

2.  A case of anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor.

Authors:  Toru Murata; Masaki Terasaki; Kenji Sakaguchi; Masayuki Okubo; Yasuyuki Fukami; Kazumi Nishimae; Yasuhiko Kitayama; Shoji Hoshi
Journal:  Clin J Gastroenterol       Date:  2009-01-15

3.  Granulocyte-colony stimulating factor-producing pancreatic cancer: report of a case.

Authors:  Kazuhiro Takami; Koh Miura; Heigo Takeuchi; Shin-Ichi Egawa; Takuya Moriya; Yasushi Nakamura; Atushi Tanabe; Jun-Ichi Sugita; Hideaki Karasawa; Michiaki Unno; Iwao Sasaki
Journal:  Surg Today       Date:  2008-04-30       Impact factor: 2.549

4.  Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case report.

Authors:  Atsushi Nakajima; Hirokazu Takahashi; Masahiko Inamori; Yasunobu Abe; Noritoshi Kobayashi; Kensuke Kubota; Shoji Yamanaka
Journal:  J Med Case Rep       Date:  2008-12-17

Review 5.  G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation.

Authors:  Ioannis Karagiannidis; Eralda Salataj; Erika Said Abu Egal; Ellen J Beswick
Journal:  Cytokine       Date:  2021-03-04       Impact factor: 3.926

6.  Granulocyte-colony stimulating factor producing anaplastic carcinoma of the pancreas treated by distal pancreatectomy and chemotherapy: report of a case.

Authors:  Hiroaki Kitade; Hidesuke Yanagida; Masanori Yamada; Sohei Satoi; Kazuhiko Yoshioka; Nobuaki Shikata; Masanori Kon
Journal:  Surg Case Rep       Date:  2015-05-30

7.  Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.

Authors:  Sahar Ghassem-Zadeh; Matthias M Gaida; Szilard Szanyi; Hans Acha-Orbea; Jean-Louis Frossard; Ulf Hinz; Thilo Hackert; Oliver Strobel; Klaus Felix
Journal:  J Transl Med       Date:  2017-06-02       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.